Endo International PLC (ENDP)

8.66
NASDAQ : Health Care
Prev Close 8.80
Day Low/High 8.49 / 8.84
52 Wk Low/High 7.41 / 23.98
Avg Volume 5.75M
Exchange NASDAQ
Shares Outstanding 223.29M
Market Cap 1.96B
EPS -15.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

We're Buying More Allergan

Stock dips due to opioid probe of drug companies.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Endo International Plc And Set A Lead Plaintiff Deadline Of October 17, 2017

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Endo International Plc And Set A Lead Plaintiff Deadline Of October 17, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Endo International plc (NASDAQ:ENDP) between November 30, 2012 and...

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Endo International Plc And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Endo International Plc And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a securities class action lawsuit against Endo International plc ("Endo" or the "Company") (Nasdaq: ENDP).

ENDO LOSS NOTICE: Rosen Law Firm Reminds Endo International Plc Investors Of Important Deadline In Class Action - ENDP

ENDO LOSS NOTICE: Rosen Law Firm Reminds Endo International Plc Investors Of Important Deadline In Class Action - ENDP

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Endo International plc (NASDAQ:ENDP) from November 30, 2012 through July 6, 2017, inclusive (the "Class Period") of the important...

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Endo International Plc

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Endo International Plc

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc ("Endo" or the "Company") (Nasdaq: ENDP) for violations of §§10(b) and...

The Klein Law Firm Notifies Investors Of Commencement Of A Class Action Filed On Behalf Of Endo International Plc Shareholders And A Lead Plaintiff Deadline Of October 17, 2017

The Klein Law Firm Notifies Investors Of Commencement Of A Class Action Filed On Behalf Of Endo International Plc Shareholders And A Lead Plaintiff Deadline Of October 17, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Endo International plc (NASDAQ: ENDP) who purchased shares between November 30, 2012 and July 6, 2017.

Short Interest In Endo International Jumps 29.4%

Short Interest In Endo International Jumps 29.4%

The most recent short interest data has been released for the 08/31/2017 settlement date, which shows a 5,655,757 share increase in total short interest for Endo International plc , to 24,909,389, an increase of 29.38% since 08/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

ENDP EQUITY ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Endo International Plc And A Lead Plaintiff Deadline Of October 17, 2017

ENDP EQUITY ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Endo International Plc And A Lead Plaintiff Deadline Of October 17, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased Endo International...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Endo International Plc - ENDP

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Endo International Plc - ENDP

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Endo International plc (NASDAQ:ENDP) from November 30, 2012 through July 6,...

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Endo International Plc

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Endo International Plc

The Klein Law Firm announces the commencement of an investigation of Endo International plc (NASDAQ:ENDP) concerning possible violations of federal securities laws.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Endo International Plc

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Endo International Plc

The Klein Law Firm announces the commencement of an investigation of Endo International plc (NASDAQ: ENDP) concerning possible violations of federal securities laws.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Endo International Plc And Set A Lead Plaintiff Deadline Of October 17, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Endo International Plc And Set A Lead Plaintiff Deadline Of October 17, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Endo International plc (NASDAQ:ENDP) between November 30, 2012 and...

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Illumina, Spark Therapeutics and Endo International were among the biotech stock movers in premarket trading on Aug. 2.

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Geron and Endo and were among the biotech stock movers on Aug. 1.

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

McCaskill requested that four more drug companies and three drug distributors turn over documents.

Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid

Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid

IntelliPharmaceuticals has a bio-equivalent to OxyContin, but says it is harder to tamper with. The pharma company is hoping to gain a recommendation from an FDA committee on Wednesday.

3 Biotech Stocks on Readers' Minds

3 Biotech Stocks on Readers' Minds

We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.

ENDP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Endo International Plc

ENDP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Endo International Plc

The Law Offices of Vincent Wong reminds investors of an investigation concerning whether Endo International plc ("Endo") (NASDAQ:ENDP) violated federal securities laws.

Trump's FDA: A Friendlier Biotech Sheriff

Trump's FDA: A Friendlier Biotech Sheriff

There still will be winners and losers, but the new administration's FDA is a net plus for the industry.

Endo's Potential Next Steps After Pulling Opioid Pain Med

Endo's Potential Next Steps After Pulling Opioid Pain Med

The pharmaceutical company has opted to voluntarily remove Opana ER from the market following the FDA's request.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Endo International Plc - ENDP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Endo International Plc - ENDP

Pomerantz LLP is investigating claims on behalf of investors of Endo International plc ("Endo" or the "Company") (NASDAQ:ENDP).

TheStreet Quant Rating: D (Sell)